Research Analysts Issue Forecasts for BBWI FY2025 Earnings

Bath & Body Works, Inc. (NYSE:BBWI) – Investment analysts at Telsey Advisory Group lifted their FY2025 earnings per share estimates for Bath & Body Works in a research note issued on Tuesday, November 26th. Telsey Advisory Group analyst D. Telsey now expects that the company will earn $3.28 per share for the year, up from their prior estimate of $3.24. Telsey Advisory Group has a “Outperform” rating and a $42.00 price objective on the stock. The consensus estimate for Bath & Body Works’ current full-year earnings is $3.18 per share. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%.

Several other brokerages also recently weighed in on BBWI. Evercore ISI reduced their price target on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. BMO Capital Markets restated an “outperform” rating and set a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. Bank of America reduced their price target on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a report on Thursday, August 29th. Citigroup reduced their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. Finally, The Goldman Sachs Group reduced their price target on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.88.

Bath & Body Works Trading Up 2.0 %

BBWI opened at $35.92 on Wednesday. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a fifty day simple moving average of $30.81 and a two-hundred day simple moving average of $35.65. The company has a market cap of $7.87 billion, a price-to-earnings ratio of 8.83, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. CWM LLC lifted its position in shares of Bath & Body Works by 6.6% during the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after buying an additional 314 shares in the last quarter. Northwest Bank & Trust Co lifted its position in shares of Bath & Body Works by 2.5% during the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after buying an additional 315 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its position in shares of Bath & Body Works by 1.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after buying an additional 322 shares in the last quarter. TD Private Client Wealth LLC lifted its position in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares in the last quarter. Finally, Citizens & Northern Corp lifted its position in shares of Bath & Body Works by 1.7% during the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock valued at $1,151,000 after buying an additional 487 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Gina Boswell acquired 6,000 shares of the stock in a transaction dated Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.27% of the company’s stock.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.23%. Bath & Body Works’s payout ratio is 19.51%.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.